GT
RETA

Glenmede Trust’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Glenmede Trust’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$591K Hold
2023
Q1 		$591K Buy
2020
Q4 		– Sell
2020
Q3 		$38K Sell
2020
Q2 		$165K Sell
2020
Q1 		$354K Hold
2019
Q4 		$354K Buy
2019
Q3 		$37 Buy
2019
Q2 		$43 Hold
2019
Q1 		$39 Buy